Paper8872500
Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.
Li J and 3 others. Inflammation, 1996. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro. Papers, record 8872500. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8872500
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelium, Vascular | Major topic |
| Interleukin-2 | Major topic |
| Neutrophils | Major topic |
| Adult | |
| CD18 Antigens | |
| Capillary Leak Syndrome | |
| Cell Adhesion | |
| Cell Adhesion Molecules | |
| Cells, Cultured | |
| Humans | |
| N-Formylmethionine Leucyl-Phenylalanine | |
| Receptors, Interleukin-2 | |
| Recombinant Proteins | |
| Umbilical Veins |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8436829 | Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta. | J Immunol | 1993 | https://conductscience.org/library/papers/8436829 | PubMed |
| 2 | 8112867 | Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia. | Infect Immun | 1994 | https://conductscience.org/library/papers/8112867 | PubMed |
| 3 | 3143745 | Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3143745 | PubMed |
| 4 | 3258138 | Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial. | Ann Intern Med | 1988 | https://conductscience.org/library/papers/3258138 | PubMed |
| 5 | 7981154 | Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. | Int Immunol | 1994 | https://conductscience.org/library/papers/7981154 | PubMed |
| 6 | 1917149 | The systemic complement activation caused by interleukin-2/lymphokine-activated killer-cell therapy of cancer causes minimal systemic neutrophil activation. | Int J Cancer | 1991 | https://conductscience.org/library/papers/1917149 | PubMed |
| 7 | 1549576 | The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1549576 | PubMed |
| 8 | 8054514 | Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity. | In Vivo | 1994 | https://conductscience.org/library/papers/8054514 | PubMed |
| 9 | 3262010 | Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells. | Cancer Res | 1988 | https://conductscience.org/library/papers/3262010 | PubMed |
| 10 | 3711336 | Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3711336 | PubMed |
| 11 | 7919341 | Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells. | Blood | 1994 | https://conductscience.org/library/papers/7919341 | PubMed |
| 12 | 3493433 | Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3493433 | PubMed |
| 13 | 1596901 | Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage. | Cancer Res | 1992 | https://conductscience.org/library/papers/1596901 | PubMed |
| 14 | 8380826 | Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. | J Immunol | 1993 | https://conductscience.org/library/papers/8380826 | PubMed |
| 15 | 1733448 | The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1733448 | PubMed |
| 16 | 7861762 | Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro. | J Surg Res | 1995 | https://conductscience.org/library/papers/7861762 | PubMed |
| 17 | 8026467 | Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. | EMBO J | 1994 | https://conductscience.org/library/papers/8026467 | PubMed |
| 18 | 3279124 | Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. | J Immunol | 1988 | https://conductscience.org/library/papers/3279124 | PubMed |
| 19 | 7882594 | Role of TNF alpha, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy. | Clin Immunol Immunopathol | 1995 | https://conductscience.org/library/papers/7882594 | PubMed |
| 20 | 3262487 | Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. | Chest | 1988 | https://conductscience.org/library/papers/3262487 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42732002 | Orphan GPR84 facilitates uropod de-adhesion at multiple steps during leukocyte extravasation. | EMBO Rep | 2026 | https://conductscience.org/library/papers/42732002 | PubMed |
| 41353412 | An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights and evaluation of mitigation strategies. | Sci Rep | 2025 | https://conductscience.org/library/papers/41353412 | PubMed |
| 40811745 | Immune cells play a critical role in cytokine- and endotoxin-mediated endothelial permeability. | PLoS One | 2025 | https://conductscience.org/library/papers/40811745 | PubMed |
| 39370477 | Breaking a dogma: orthodontic tooth movement alters systemic immunity. | Prog Orthod | 2024 | https://conductscience.org/library/papers/39370477 | PubMed |
| 38967887 | Association of serum interleukin-2 with severity and prognosis in hospitalized patients with community-acquired pneumonia: a prospective cohort study. | Intern Emerg Med | 2024 | https://conductscience.org/library/papers/38967887 | PubMed |
| 38474145 | Human Macrophages Activate Bystander Neutrophils' Metabolism and Effector Functions When Challenged with Mycobacterium tuberculosis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474145 | PubMed |
| 38087370 | Targeting the myeloid microenvironment in neuroblastoma. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/38087370 | PubMed |
| 34734110 | Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress. | Adv Ther (Weinh) | 2021 | https://conductscience.org/library/papers/34734110 | PubMed |
| 33105656 | The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33105656 | PubMed |
| 25083614 | A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. | Transplantation | 2015 | https://conductscience.org/library/papers/25083614 | PubMed |
| 24127752 | On-chip evaluation of neutrophil activation and neutrophil-endothelial cell interaction during neutrophil chemotaxis. | Anal Chem | 2013 | https://conductscience.org/library/papers/24127752 | PubMed |
| 22816782 | Neutrophil chemotaxis within a competing gradient of chemoattractants. | Anal Chem | 2012 | https://conductscience.org/library/papers/22816782 | PubMed |
| 21606942 | Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase. | Immunol Cell Biol | 2012 | https://conductscience.org/library/papers/21606942 | PubMed |
| 15685449 | Local interleukin 2 therapy is most effective against cancer when injected intratumourally. | Cancer Immunol Immunother | 2005 | https://conductscience.org/library/papers/15685449 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| IL2RB | 3560 | PubTator's text mining | https://conductscience.org/library/genes/3560 | NCBI Gene |
| ITGB2 | 3689 | PubTator's text mining | https://conductscience.org/library/genes/3689 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8872500
GET https://conductscience.org/api/papers/v1/8872500/references?page=2